Photobiomodulation for non‐exudative age‐related macular degeneration
References
Additional references
Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200.
Age‐Related Eye Disease Study Research Group. A randomized, placebo‐controlled, clinical trial of high‐dose supplementation with vitamins C and E, beta carotene, and zinc for age‐related macular degeneration and vision loss: AREDS report number 8. Archives of Ophthalmology 2001;119(10):1417‐36.
Begum R, Powner MB, Hudson N, Hogg C, Jeffery G. Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age‐related macular degeneration mode. PLoS One 2013;8(2):e57828.
Berdeaux GH, Nordmann JP, Colin E, Arnould B. Vision‐related quality of life in patients suffering from age‐related macular degeneration. American Journal of Ophthalmology 2005;139(2):271‐9.
Veritas Health Innovation. Covidence. Version accessed prior to 31 October 2017. Melbourne, Australia: Veritas Health Innovation.
Fitzgerald M, Hodgetts S, Van Den Heuvel C, Natoli R, Hart NS, Valter K, et al. Red/near‐infrared irradiation therapy for treatment of central nervous system injuries and disorders. Reviews in Neuroscience 2013;24(2):205‐26.
Fuma S, Murase H, Kuse Y, Tsuruma K, Shimazawa M, Hara H. Photobiomodulation with 670 nm light increased phagocytosis in human retinal pigment epithelial cells. Molecular Vision 2015;21:883‐92.
Glanville JM, Lefebvre C, Miles JN, Camosso‐Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130‐6.
McMaster University (developed by Evidence Prime). GRADEpro GDT. Version Version accessed prior to 31 October 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
Guymer RH, Brassington KH, Dimitrov P, Makeyeva G, Plunkett M, Xia W, et al. Nanosecond‐laser application in intermediate AMD: 12‐month results of fundus appearance and macular function. Clinical & Experimental Ophthalmology 2014;42(5):466‐79.
Higgins J, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58.
Higgins JP, Altman DG, Sterne JAC editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
James Lind Alliance Sight Loss, Vision Priority Setting Partnership. Setting Priorities for Eye Research. www.sightlosspsp.org.uk 2018.
Jobling AI, Guymer RH, Vessey KA, Greferath U, Mills SA, Brassington KH, Luu CD, Aung KZ, Trogrlic L, Plunkett M, Fletcher EL. Nanosecond laser therapy reverses pathologic and molecular changes in age‐related macular degeneration without retinal damage. FASEB Journal 2015;29(2):696‐710.
Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen‐year cumulative incidence of age‐related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007;114(2):253‐62.
Kokkinopoulos I, Colman A, Hogg C, Heckenlively J, Jeffery G. Age‐related retinal inflammation is reduced by 670 nm light via increased mitochondrial membrane potential. Neurobiology of Aging 2013;34(2):602‐9.
Macular Society. Your guided to age‐related macular degeneration. www.macularsociety.org/sites/default/files/resource/Macular Society Guide to AMD accessible pdf MS002 JUN17.pdf (accessed prior to 31 October 2017).
Owsley C, McGwin G, Scilley K, Kallies K. Development of a questionnaire to assess vision problems under low luminance in age‐related maculopathy. Investigative Ophthalmology & Visual Science 2006;47(2):528‐35.
Owsley C, McGwin G, Jackson GR, Kallies K, Clark M. Cone‐ and rod‐mediated dark adaptation impairment in age‐related maculopathy. Ophthalmology 2007;114(9):1728‐35.
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
D Minassian, A Reidy, RNIB. Future sight loss in the decade 2010 to 2020: an epidemiological and economic model. www.rnib.org.uk/sites/default/files/FSUK_Report_2.doc (accessed prior to 31 October 2017).
Rutar M, Natoli R, Albarracin R, Valter K, Provis J. 670‐nm light treatment reduces complement propagation following retinal degeneration. Journal of Neuroinflammation 2012;26(9):257.
Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C. Early age‐related maculopathy and self‐reported visual difficulty in daily life. Ophthalmology 2002;109(7):1235‐42.
Sivapathasuntharama C, Sivaprasad S, Hogg C, Jeffery G. Aging retinal function is improved by near infrared light (670 nm) that is associated with corrected mitochondrial decline. Neurobiology of Aging 2017;52:66‐70.
